Vermeiden Sie Betrug, informieren Sie sich und finden Sie das Beste
Legal Name: FARALLON CAPITAL MANAGEMENT, L.L.C.
Berichtszeitraum:
Jun 30, 2019
Gültigkeitsdatum:
Aug 14, 2019
| Sicherheit |
Gehaltene Aktien / Nennbetrag |
Marktwert |
Möglichkeit |
|
AABA (021346101)
|
28,362,317 |
$1,967,494k |
|
|
SPDR S&P 500 ETF TR TR UNIT (78462F103)
|
3,647,500 |
$1,068,718k |
Put |
|
ANADARKO PETE (032511107)
|
10,465,000 |
$738,410k |
|
|
WABTEC (929740108)
|
6,568,373 |
$471,346k |
|
|
IQVIA HOLDINGS INC (46266C105)
|
2,579,011 |
$414,963k |
|
|
Array Biopharma Inc (04269X105)
|
8,500,000 |
$393,805k |
|
|
FIDELITY NATL INFO (31620M106)
|
2,842,640 |
$348,735k |
|
|
ANTHEM INC (036752103)
|
1,050,000 |
$296,321k |
|
|
CHARTER COMMUNICATIO (16119P108)
|
700,405 |
$276,786k |
|
|
GENERAL DYNAMICS (369550108)
|
1,335,214 |
$242,769k |
|
|
PLAYA HOTELS & RESOR (N70544106)
|
30,606,930 |
$235,979k |
|
|
IHS MARKIT LTD (G47567105)
|
3,604,997 |
$229,710k |
|
|
SHERWIN WILLIAMS CO (824348106)
|
465,699 |
$213,425k |
|
|
VISA INC COM CL A (92826C839)
|
1,187,779 |
$206,139k |
|
|
EQUIFAX INC (294429105)
|
1,463,779 |
$197,961k |
|
|
EQUINIX INC (29444U700)
|
383,132 |
$193,210k |
|
|
S&P GLOBAL INC (78409V104)
|
840,786 |
$191,523k |
|
|
CITRIX SYS INC (177376100)
|
1,916,051 |
$188,041k |
|
|
Booking Holdings, Inc. (09857L108)
|
97,449 |
$182,689k |
|
|
ASCENDIS PHARMA A S (04351P101)
|
1,540,000 |
$177,331k |
|
|
Facebook Inc (30303M102)
|
904,284 |
$174,527k |
|
|
ASTRAZENECA (046353108)
|
4,100,000 |
$169,248k |
|
|
MICROSOFT CORP (594918104)
|
1,257,503 |
$168,455k |
|
|
CIGNA CORP (125523100)
|
1,050,000 |
$165,428k |
|
|
Alphabet Inc (02079K107)
|
142,223 |
$153,730k |
|
|
Iovance Biotherapeutics Inc (462260100)
|
5,725,000 |
$140,377k |
|
|
TransUnion (89400J107)
|
1,672,343 |
$122,934k |
|
|
SEA LTD (81141R100)
|
3,375,000 |
$112,118k |
|
|
MIRATI THERAPEUTICS INC (60468T105)
|
995,000 |
$102,485k |
|
|
MYOKARDIA INC (62857M105)
|
2,000,000 |
$100,280k |
|
|
Acceleron Pharma Inc (00434H108)
|
2,375,000 |
$97,565k |
|
|
LIBERTY GLOBAL PLC (G5480U120)
|
3,675,974 |
$97,524k |
|
|
ZOGENIX INC (98978L204)
|
2,000,000 |
$95,560k |
|
|
ZAYO GROUP HLDGS INC (98919V105)
|
2,820,000 |
$92,806k |
|
|
Sage Therapeutics Inc (78667J108)
|
500,000 |
$91,545k |
|
|
ALIBABA GROUP HLDG LTD (01609W102)
|
500,000 |
$84,725k |
|
|
B. Riley Wealth Management, Inc. (023111206)
|
4,250,000 |
$82,408k |
|
|
ENANTA PHARMACEUTI (29251M106)
|
960,000 |
$81,005k |
|
|
ALNYLAM PHARMACEUTICALS INC (02043Q107)
|
1,100,000 |
$79,816k |
|
|
GENESEE & WYO INC (371559105)
|
775,000 |
$77,500k |
|
|
FIBROGEN INC (31572Q808)
|
1,700,000 |
$76,806k |
|
|
Sarepta Therapeutics Inc (803607100)
|
500,000 |
$75,975k |
|
|
NOVOCURE LTD (G6674U108)
|
1,200,000 |
$75,876k |
|
|
Reata Pharmaceuticals Inc. (75615P103)
|
800,000 |
$75,480k |
|
|
SPRINT CORPORATION (85207U105)
|
10,675,000 |
$70,135k |
|
|
GRIFOLS S A (398438408)
|
3,080,083 |
$64,990k |
|
|
EXELIXIS INC (30161Q104)
|
3,000,000 |
$64,110k |
|
|
GLOBAL BLOOD THERAPEUTICS IN (37890U108)
|
1,125,000 |
$59,175k |
|
|
LIBERTY GLOBAL PLC (G5480U104)
|
2,083,977 |
$56,247k |
|
|
ARROWHEAD PHARMACEUT (04280A100)
|
2,000,000 |
$53,000k |
|
|
Fate Therapeutics Inc (31189P102)
|
2,500,000 |
$50,750k |
|
|
RADIUS HEALTH INC (750469207)
|
2,043,149 |
$49,771k |
|
|
CVS HEALTH CORP (126650100)
|
822,500 |
$44,818k |
|
|
Fox Corp (35137L204)
|
1,182,500 |
$43,197k |
|
|
NXP Semiconductors NV (N6596X109)
|
430,000 |
$41,972k |
|
|
ZYMEWORKS INC (98985W102)
|
1,756,470 |
$38,642k |
|
|
FIRST DATA CORP (32008D106)
|
1,425,000 |
$38,575k |
|
|
PROGENICS PHARMACEUTICALS INCO (743187106)
|
5,543,386 |
$34,203k |
|
|
READY CAP CORP (75574U101)
|
2,243,239 |
$33,424k |
|
|
T MOBILE US INC COM USD0.00001 (872590104)
|
425,780 |
$31,567k |
|
|
FOX CORPORATION (35137L105)
|
836,400 |
$30,646k |
|
|
PTC THERAPEUTICS INC (69366J200)
|
600,000 |
$27,000k |
|
|
PTC THERAPEUTICS INC (69366JAB7)
|
24,130,000 |
$26,705k |
|
|
CRISPR Therapeutics AG (H17182108)
|
500,000 |
$23,550k |
|
|
QUOTIENT LTD COM NPV (G73268107)
|
2,500,000 |
$23,375k |
|
|
Codexis Inc (192005106)
|
1,250,000 |
$23,038k |
|
|
STEMLINE THERAPEUTICS INC (85858C107)
|
1,500,000 |
$22,980k |
|
|
SINA CORPORATION (G81477104)
|
510,000 |
$21,996k |
|
|
ZEALAND PHARMA A S (98920Y304)
|
1,000,000 |
$21,550k |
|
|
Invitae Corp (46185L103)
|
900,000 |
$21,150k |
|
|
CARA THERAPEUTICS (140755109)
|
951,326 |
$20,454k |
|
|
Voyager Therapeutics Inc (92915B106)
|
750,000 |
$20,415k |
|
|
CHEMOCENTRYX INC (16383L106)
|
2,000,000 |
$18,600k |
|
|
PROTAGONIST THERAPEUTICS INC (74366E102)
|
1,500,000 |
$18,165k |
|
|
AVROBIO INC (05455M100)
|
1,036,147 |
$16,848k |
|
|
CLOVIS ONCOLOGY INC (189464AC4)
|
18,750,000 |
$11,684k |
|
|
NanoString Technologies Inc (63009R109)
|
350,000 |
$10,623k |
|
|
Eiger Biopharmaceuticals Inc (28249U105)
|
1,000,000 |
$10,600k |
|
|
Voya Financial Inc. (929089100)
|
185,000 |
$10,231k |
|
|
Veracyte Inc (92337F107)
|
350,000 |
$9,979k |
|
|
PHASEBIO PHARMACEUTICALS INC (717224109)
|
756,961 |
$9,931k |
|
|
TWIST BIOSCIENCE CORP COM (90184D100)
|
307,055 |
$8,908k |
|
|
SAVARA INC (805111101)
|
3,475,000 |
$8,236k |
|
|
UNIQURE N.V. (N90064101)
|
100,000 |
$7,815k |
|
|
MILESTONE PHARMACEUTICALS IN (59935V107)
|
250,000 |
$6,788k |
|
|
CYCLERION THERAPEUTI (23255M105)
|
544,085 |
$6,230k |
|
|
SCTY 1 5/8 11/01/19 (83416TAC4)
|
5,500,000 |
$5,304k |
|
|
PERSONALIS INC (71535D106)
|
184,932 |
$5,021k |
|
|
PFENEX INC (717071104)
|
600,000 |
$4,044k |
|
|
SANOFI (80105N113)
|
6,827,805 |
$3,550k |
|
|
AKERO THERAPEUTICS INC (00973Y108)
|
150,000 |
$2,873k |
|
|
APTINYX INC COM (03836N103)
|
670,000 |
$2,238k |
|
|
GOSSAMER BIO INC (38341P102)
|
100,000 |
$2,218k |
|
|
ZAFGEN INC (98885E103)
|
1,800,000 |
$2,142k |
|
|
Assembly Biosciences Inc (045396108)
|
100,000 |
$1,349k |
|
|
ADAPTIVE BIOTECHNOLOGIES COR (00650F109)
|
25,000 |
$1,208k |
|
|
RADIUS HEALTH INC (750469AA6)
|
1,250,000 |
$1,132k |
|
|
Occidental Petroleum Corp (674599105)
|
20,000 |
$1,006k |
|
Viele Menschen wurden durch Betrug und Ponzi-Vorhaben verbrannt. Deshalb haben wir diese Website erstellt, um Ihnen als potenziellem Investor dabei zu helfen, die Fakten zu ermitteln, die besten zu finden und Betrugs- und Ponzi-Vorhaben zu vermeiden.
Alle auf dieser Website bereitgestellten Informationen werden ohne Gewähr und nur zu Informationszwecken bereitgestellt.
InvestingReview.org bietet keine Anlageberatung an. InvestingReview.org ist kein Anlageberater und wird von keiner US-amerikanischen oder nicht US-amerikanischen Aufsichtsbehörde unterstützt oder ist mit dieser verbunden.
Kürzlich gesuchte Firmen
Bitte beachten Sie: Die Suchdaten werden von Dritten gesammelt und einmal täglich aktualisiert.